U.S. Medical Equipment Stock News

NasdaqGS:LINC
NasdaqGS:LINCConsumer Services

Insider Selling At Lincoln Educational Raises Questions On Rich Valuation

Director at Lincoln Educational Services (NasdaqGS:LINC) recently executed a sizable share sale, extending a pattern of insider selling. Recent filings show continued insider disposals over time, with no offsetting insider purchases reported. The cluster of sales focuses attention on board sentiment and governance signals that are not visible in headline financials. Lincoln Educational Services, listed on the NasdaqGS under the ticker LINC, operates career-focused education programs that...
NasdaqGM:SIGA
NasdaqGM:SIGAPharmaceuticals

SIGA Technologies (SIGA) Margin Compression Challenges Bullish Narratives After FY 2025 Results

SIGA Technologies (SIGA) has just wrapped up FY 2025 with a mixed earnings print, as fourth quarter revenue came in at about US$3.8 million and basic EPS landed at a loss of US$0.08, while the trailing 12 month figures show total revenue of roughly US$94.6 million and basic EPS of US$0.33. The company has seen quarterly revenue move from US$81.5 million in Q4 2024 to US$81.1 million in Q2 2025 before easing back to US$3.8 million in Q4 2025, with EPS shifting from US$0.64 in Q4 2024 to...
NYSE:KMT
NYSE:KMTMachinery

Kennametal Talent Leader Recognition Highlights Culture As Investment Consideration

Kennametal executive Ellen Whittingham has been named a 2026 STEP Ahead Award Honoree. The award recognizes her leadership and work in talent development within the manufacturing sector. This recognition highlights Kennametal's focus on workplace culture and leadership depth at NYSE:KMT. Kennametal, listed on NYSE:KMT, supplies tooling and industrial materials to customers across metalworking and related manufacturing fields. Recognition for an executive focused on leadership and talent...
NYSE:BLND
NYSE:BLNDSoftware

Blend Labs (BLND) TTM Loss Improvement Challenges Bearish Profitability Narratives

Blend Labs (BLND) just posted its FY 2025 fourth quarter numbers, with revenue of US$32.4 million and a basic EPS loss of US$0.03, while net income excluding extra items came in at a loss of US$7.1 million. The company has seen quarterly revenue move from US$41.4 million in Q4 2024 to US$32.4 million in Q4 2025, with basic EPS shifting from a loss of US$0.03 in Q4 2024 to a loss of US$0.03 in the latest quarter. As a result, this reporting period is likely to draw attention to how the loss...
NasdaqGS:STRA
NasdaqGS:STRAConsumer Services

Does Strategic Education (STRA) Offer Value After Recent Share Price Softness?

If you are wondering whether Strategic Education's current share price still represents solid value, the recent data gives you plenty to think about. The stock closed at US$78.87 recently, with returns of a 3.3% decline over 7 days and a 1.3% decline over 30 days, while year to date it is up 0.4% and the 1-year return sits at 1.6%. These steady but modest return figures over the past year, including 0.8% over 3 years and 4.6% over 5 years, suggest the market has been cautious in how it...
NYSE:GBTG
NYSE:GBTGHospitality

Global Business Travel Group’s Transformation Raises Questions On Value And Execution

Global Business Travel Group (NYSE:GBTG) has completed its acquisition of CWT, reaching what management calls an inflection point in its business transformation. The company is rolling out Egencia AI, which management says is already contributing to measurable revenue and cost efficiencies. GBTG reports strong revenue growth and profitability in 2025 alongside accelerated integration, restructuring, and productivity efforts. For investors watching NYSE:GBTG, the share price at $5.57 sits...
NasdaqGS:DAWN
NasdaqGS:DAWNBiotechs

Servier All Cash Deal Reframes Day One Biopharmaceuticals Valuation Story

Servier Pharmaceuticals has entered into a definitive agreement to acquire Day One Biopharmaceuticals, NasdaqGS:DAWN, in an all cash transaction. The deal marks a material change in ownership, bringing Day One Biopharmaceuticals under Servier control and ending its status as an independent company once the transaction closes. Day One Biopharmaceuticals focuses on developing and commercializing oncology therapies, a segment that has seen frequent partnerships, licensing arrangements, and...
NasdaqCM:TSSI
NasdaqCM:TSSIIT

TSS (TSSI) Quarterly Loss And 2.1% Margin Test Bullish Growth Narratives

Transaction Systems Services (TSS) closed its FY 2025 third quarter with revenue of US$41.9 million, Basic EPS of US$0.06 loss and net income excluding extra items of US$1.5 million loss. The trailing twelve months show revenue of US$234.8 million, Basic EPS of US$0.20 and net income of US$4.9 million. Over recent periods, the company has seen quarterly revenue move between US$12.2 million and US$99.0 million, with Basic EPS ranging from US$0.06 loss to US$0.13 per share. Net income excluding...
NasdaqGM:KDK
NasdaqGM:KDKAuto Components

Kodiak AI (KDK) Cash Burn Overwhelms FY 2025 Revenue And Challenges Bullish Narratives

Kodiak AI (KDK) just wrapped up FY 2025 with Q4 revenue of US$1.1 million and a basic EPS loss of US$0.42. The trailing twelve months show revenue of US$16.5 million and a basic EPS loss of US$5.74. The company reported TTM revenue of US$14.9 million in FY 2024, alongside a basic EPS loss of US$0.79, giving investors a clearer view of how the top line and per share losses have been tracking into this latest result and providing context for the 6.5% revenue growth figure reported over the past...
NasdaqGM:ARQ
NasdaqGM:ARQChemicals

A Look At Arq’s Valuation As GAC Production Is Halted And Corbin Facility Is Idled

Why Arq’s halted GAC production matters for investors Arq (ARQ) has paused granular activated carbon production after independent testing highlighted equipment capacity limits. The company has idled its Corbin facility and recorded a non cash impairment charge tied to long lived assets in the fourth quarter of 2025. See our latest analysis for Arq. The halted GAC production, large non cash impairment and wider 2025 loss sit against a weak share price backdrop, with a 30 day share price return...
NYSE:HTT
NYSE:HTTConsumer Finance

High Templar Tech FY 2025 Margin Strength Challenges Bearish Profitability Narratives

High Templar Tech (HTT) has put up a punchy set of FY 2025 numbers, with Q3 revenue of C¥8.5 million, basic EPS of C¥2.55 and trailing 12 month EPS of C¥4.86 backed by very large year over year earnings growth and an 18% net profit margin. The company has seen quarterly revenue shift from C¥55.0 million in Q3 2024 to C¥8.5 million in Q3 2025, while basic EPS moved from C¥0.73 to C¥2.55 over the same stretch. This sets up a results season where the key question is how durable this earnings...
NYSE:TG
NYSE:TGMetals and Mining

Tredegar (TG) Q3 Return To Underlying Profitability Tests Bearish Narratives

Tredegar (TG) has posted its latest FY 2025 numbers with third quarter revenue at about US$194.9 million and basic EPS of roughly US$0.20, alongside trailing twelve month revenue of US$691.2 million and EPS of about US$0.07 that reflects the impact of a US$19.9 million one off loss. The company has seen quarterly revenue move from US$146.0 million in Q3 2024 to US$194.9 million in Q3 2025, while basic EPS has shifted from roughly a US$0.10 loss to about US$0.20. This gives investors a cleaner...
NYSE:OPFI
NYSE:OPFIConsumer Finance

OppFi (OPFI) Q3 EPS Rebound To US$1.48 Tests Bearish Profitability Narrative

OppFi (OPFI) has delivered a sharp swing in its latest quarter, with Q3 2025 revenue of US$94.5 million and basic EPS of US$1.48, alongside net income of US$41.6 million. The company has reported revenue of US$75.3 million in Q2 2024, US$90.5 million in Q2 2025, and US$94.5 million in Q3 2025. Over the same periods, EPS moved from US$0.16 in Q2 2024 to a loss of US$0.78 in Q2 2025, before rebounding to US$1.48 in Q3 2025. This sets up a results season in which investors are likely to focus...
NYSE:SDHC
NYSE:SDHCConsumer Durables

Smith Douglas Homes (SDHC) Margin Compression Challenges Bullish Growth Narrative In FY 2025 Q3

Smith Douglas Homes (SDHC) has just posted its FY 2025 third quarter results, with revenue of US$262.0 million, basic EPS of US$0.24 and net income of US$2.1 million, providing a reference point for how investors assess its current profitability. The company has seen quarterly revenue shift from US$220.9 million in FY 2024 Q2 to US$277.8 million in Q3 and US$287.5 million in Q4, then move through US$224.7 million, US$223.9 million and now US$262.0 million over the first three quarters of FY...
NasdaqGM:CPSS
NasdaqGM:CPSSConsumer Finance

Consumer Portfolio Services (CPSS) Margin Compression Tests Bullish Growth Narrative

Consumer Portfolio Services (CPSS) just wrapped up FY 2025 with Q4 revenue of US$50.6 million and basic EPS of US$0.23, anchored by net income of US$5.0 million. The company has seen quarterly revenue move from US$45.8 million in Q3 2024 to US$50.6 million in Q4 2025, while EPS has ranged between roughly US$0.22 and US$0.24 over that stretch, and trailing 12 month revenue and EPS most recently sat at US$205.4 million and US$0.88 respectively. With net profit margin running at 9.9% over the...
NasdaqGS:GRPN
NasdaqGS:GRPNMultiline Retail

Groupon (GRPN) Returns To Q4 Profit As EPS Turnaround Tests Bearish Narratives

Groupon (GRPN) closed FY 2025 with fourth quarter revenue of US$132.7 million and basic EPS of US$0.18, alongside trailing 12 month revenue of US$498.4 million and a basic EPS loss of US$2.06. Over recent quarters, the company has reported revenue between US$114.5 million and US$132.7 million per quarter. Basic EPS has moved from a loss of US$2.92 in Q3 2025 to a profit of US$0.18 in Q4 2025. Investors are weighing these recent quarterly profits against a still negative trailing earnings base...
NasdaqGS:ACTG
NasdaqGS:ACTGDiversified Financial

Acacia Research (ACTG) Q3 Loss And Thin 1.7% Margin Challenge Bullish Profitability Narrative

Acacia Research (ACTG) has just posted its FY 2025 third quarter numbers, with revenue of US$59.4 million and a loss of US$2.7 million, or EPS of US$0.03. This is set against a trailing twelve month net profit margin of 1.7% that includes a US$2.4 million one off gain. The company has seen quarterly revenue move from US$25.8 million in Q2 2024 to US$48.8 million in Q4 2024, then US$124.4 million, US$51.2 million and US$59.4 million through Q3 2025. EPS has ranged from a loss of US$0.08 to a...
NasdaqGM:WEST
NasdaqGM:WESTFood

Westrock Coffee (WEST) Losses Near US$90 Million Test Bullish Turnaround Narrative

Westrock Coffee (WEST) just closed out FY 2025 with Q4 revenue of US$339.5 million and a basic EPS loss of US$0.23, alongside a trailing twelve month revenue figure of US$1.19 billion and a full year EPS loss of US$0.94. Over the last six reported quarters, revenue has moved from US$220.9 million in Q3 2024 to US$339.5 million in Q4 2025. Quarterly basic EPS losses ranged between US$0.16 and US$0.29, leaving investors focused on how quickly margins can move toward breakeven. See our full...
NYSE:BNED
NYSE:BNEDSpecialty Retail

Barnes And Noble Education Q3 EPS Profit Challenges Persistent Bearish Narratives On Sustainability

Barnes & Noble Education (BNED) has just posted Q3 2026 revenue of US$515.1 million with basic EPS of US$0.19, on net income of US$6.7 million and same store sales growth of 7.2%. Over recent quarters, revenue has moved from US$466.3 million in Q3 2025 to US$644.4 million in Q2 2026 and then to US$515.1 million in Q3 2026. Basic EPS shifted from US$0.23 in Q3 2025 to US$0.73 in Q2 2026 and US$0.19 in the latest quarter. Taken together, the results point to a business that is generating...
NYSE:CLH
NYSE:CLHCommercial Services

Clean Harbors EPA Settlement Puts Compliance And Valuation In Focus

Clean Harbors' Safety-Kleen division reached a settlement with the U.S. EPA over environmental compliance issues tied to operations in New Jersey. The company has publicly committed to improved compliance, staff retraining, and facility upgrades as part of its response. Clean Harbors (NYSE:CLH) sits at the intersection of hazardous waste management, environmental services, and industrial cleaning, all of which are closely watched by regulators. The Safety-Kleen settlement puts a spotlight...
NYSEAM:CMT
NYSEAM:CMTChemicals

Core Molding Technologies (CMT) Margin Dip To 4.1% Tests Bullish Expansion Narrative

Core Molding Technologies (CMT) has wrapped up FY 2025 with fourth quarter revenue of US$74.7 million and basic EPS of US$0.36 on net income of US$3.1 million, with the trailing twelve month figures sitting at US$273.8 million of revenue and EPS of US$1.31. Over recent periods the company has seen quarterly revenue range from US$58.4 million to US$79.2 million, with basic EPS moving between US$0.22 and US$0.47. This gives investors a clear view of how earnings power has tracked alongside the...
NYSE:LDI
NYSE:LDIDiversified Financial

LoanDepot (LDI) Q4 Loss Widens Versus Q3 And Tests Bullish Profitability Narratives

loanDepot (LDI) just wrapped up FY 2025 with Q4 revenue of US$266.6 million and a net loss of US$22.5 million, which translated to EPS of a US$0.10 loss, setting a cautious tone for the full year. The company has seen quarterly revenue move from US$164.9 million in Q4 2024 to US$266.6 million in Q4 2025, while EPS shifted from a US$0.17 loss to a US$0.10 loss over the same stretch, leaving investors focused on how much of that top line is making it through to the bottom line. The latest...
NYSE:VTOL
NYSE:VTOLEnergy Services

Bristow Group Tests Autonomous Cargo To Reshape Energy Logistics Outlook

Bristow Group (NYSE:VTOL) joined the U.S. Department of Transportation’s eVTOL Integration Pilot Program. The company is partnering with Elroy Air to deploy the Chaparral autonomous cargo drone. The program targets aerial cargo delivery opportunities for the energy sector along the U.S. Gulf Coast. Bristow Group, best known for crew transport and search and rescue services, is now stepping into autonomous aerial cargo through its work with Elroy Air. By participating in the U.S. Department...
NasdaqGM:IRON
NasdaqGM:IRONBiotechs

Is Disc Medicine (IRON) Pricing Attractive After Recent Pullback And DCF Valuation Gap

If you are trying to work out whether Disc Medicine is attractively priced today, it helps to first look at how the market has been treating the stock and what that might imply about expectations. The share price recently closed at US$66.18, with returns of 2.8% over the last 7 days, a 17.0% decline over 30 days, a 16.3% decline year to date, and a 22.8% gain over the past year. Taken together, this gives you a mixed picture of sentiment and risk. Recent news coverage around Disc Medicine...